These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 11454931)

  • 1. Compensatory up-regulation of nitric-oxide synthase isoforms in lead-induced hypertension; reversal by a superoxide dismutase-mimetic drug.
    Vaziri ND; Ding Y; Ni Z
    J Pharmacol Exp Ther; 2001 Aug; 298(2):679-85. PubMed ID: 11454931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antioxidants inhibit human endothelial cell functions through down-regulation of endothelial nitric oxide synthase activity.
    Polytarchou C; Papadimitriou E
    Eur J Pharmacol; 2005 Mar; 510(1-2):31-8. PubMed ID: 15740722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antioxidant enzymes and effects of tempol on the development of hypertension induced by nitric oxide inhibition.
    Sainz J; Wangensteen R; Rodríguez Gómez I; Moreno JM; Chamorro V; Osuna A; Bueno P; Vargas F
    Am J Hypertens; 2005 Jun; 18(6):871-7. PubMed ID: 15925750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased salt sensitivity induced by sensory denervation: role of superoxide.
    Song WZ; Chen AF; Wang DH
    Acta Pharmacol Sin; 2004 Dec; 25(12):1626-32. PubMed ID: 15569407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of inducible nitric oxide synthase in rostral ventrolateral medulla causes hypertension and sympathoexcitation via an increase in oxidative stress.
    Kimura Y; Hirooka Y; Sagara Y; Ito K; Kishi T; Shimokawa H; Takeshita A; Sunagawa K
    Circ Res; 2005 Feb; 96(2):252-60. PubMed ID: 15591232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dietary Zn deficiency does not influence systemic blood pressure and vascular nitric oxide signaling in normotensive rats.
    Sato M; Kurihara N; Moridaira K; Sakamoto H; Tamura J; Wada O; Yanagisawa H
    Biol Trace Elem Res; 2003 Feb; 91(2):157-72. PubMed ID: 12719611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of lead on nitric oxide synthase expression in coronary endothelial cells: role of superoxide.
    Vaziri ND; Ding Y
    Hypertension; 2001 Feb; 37(2):223-6. PubMed ID: 11230275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms of hypertension induced by nitric oxide (NO) deficiency: focus on venous function.
    Thakali KM; Lau Y; Fink GD; Galligan JJ; Chen AF; Watts SW
    J Cardiovasc Pharmacol; 2006 Jun; 47(6):742-50. PubMed ID: 16810074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic N-acetylcysteine administration prevents development of hypertension in N(omega)-nitro-L-arginine methyl ester-treated rats: the role of reactive oxygen species.
    Rauchová H; Pechánová O; Kunes J; Vokurková M; Dobesová Z; Zicha J
    Hypertens Res; 2005 May; 28(5):475-82. PubMed ID: 16156512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antioxidative treatment reverses imbalances of nitric oxide synthase isoform expression and attenuates tissue-cGMP activation in diabetic rats.
    Bojunga J; Dresar-Mayert B; Usadel KH; Kusterer K; Zeuzem S
    Biochem Biophys Res Commun; 2004 Apr; 316(3):771-80. PubMed ID: 15033467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lead-induced hypertension. II. Response to sequential infusions of L-arginine, superoxide dismutase, and nitroprusside.
    Ding Y; Vaziri ND; Gonick HC
    Environ Res; 1998 Feb; 76(2):107-13. PubMed ID: 9515065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiac and renal antioxidant enzymes and effects of tempol in hyperthyroid rats.
    Moreno JM; Rodríguez Gómez I; Wangensteen R; Osuna A; Bueno P; Vargas F
    Am J Physiol Endocrinol Metab; 2005 Nov; 289(5):E776-83. PubMed ID: 15941780
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxidative stress and dysregulation of superoxide dismutase and NADPH oxidase in renal insufficiency.
    Vaziri ND; Dicus M; Ho ND; Boroujerdi-Rad L; Sindhu RK
    Kidney Int; 2003 Jan; 63(1):179-85. PubMed ID: 12472781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Superoxide dismutase, catalase, glutathione peroxidase and NADPH oxidase in lead-induced hypertension.
    Vaziri ND; Lin CY; Farmand F; Sindhu RK
    Kidney Int; 2003 Jan; 63(1):186-94. PubMed ID: 12472782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nitric oxide and superoxide interactions in the kidney and their implication in the development of salt-sensitive hypertension.
    Majid DS; Kopkan L
    Clin Exp Pharmacol Physiol; 2007 Sep; 34(9):946-52. PubMed ID: 17645645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The antioxidant tempol prevents and partially reverses dexamethasone-induced hypertension in the rat.
    Zhang Y; Croft KD; Mori TA; Schyvens CG; McKenzie KU; Whitworth JA
    Am J Hypertens; 2004 Mar; 17(3):260-5. PubMed ID: 15001201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of tempol on endothelium-dependent vasodilatation and blood pressure.
    Simonsen U; Christensen FH; Buus NH
    Pharmacol Ther; 2009 May; 122(2):109-24. PubMed ID: 19268689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atrial natriuretic peptide prevents diabetes-induced endothelial dysfunction.
    Woodman OL; Malakul W; Cao AH; Xu Q; Ritchie RH
    Life Sci; 2008 Apr; 82(15-16):847-54. PubMed ID: 18302965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tempol administration, a superoxide dismutase mimetic, reduces hepatic vascular resistance and portal pressure in cirrhotic rats.
    García-Calderó H; Rodríguez-Vilarrupla A; Gracia-Sancho J; Diví M; Laviña B; Bosch J; García-Pagán JC
    J Hepatol; 2011 Apr; 54(4):660-5. PubMed ID: 21159403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Double-edged action of SOD mimetic in diabetic nephropathy.
    Asaba K; Tojo A; Onozato ML; Goto A; Fujita T
    J Cardiovasc Pharmacol; 2007 Jan; 49(1):13-9. PubMed ID: 17261958
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.